LAM
DGX icon

Longboard Asset Management’s Quest Diagnostics DGX Stock Holding History

Longboard Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Hold
1,036
– – 3.68% 15
2026
Q1 		$203K Buy
+1,036
New +$201K 3.51% 20

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SIC
Schwartz Investment Counsel Plymouth, Michigan $3.01B AUM 27.22% 1-Year Est. Return

Longboard Asset Management's DGX Position: Q2 2026 in Review

Longboard Asset Management held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,036 shares worth $220K. The position accounts for 3.68% of the portfolio, ranked #15.

Longboard Asset Management first reported a position in DGX in Q1 2026 and has held it in 2 quarters since. 380 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Longboard Asset Management held 1,036 shares of Quest Diagnostics worth $220K as of Q2 2026.
  • Longboard Asset Management left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 3.68% of Longboard Asset Management's portfolio in Q2 2026, its #15 holding.
  • Longboard Asset Management first reported a position in Quest Diagnostics in Q1 2026 and has held it in 2 quarters since.
  • 380 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Longboard Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.